Logo

SAI LIFE SCIENCES LIMITED Share Price

NSE: SAILIFE
|
Pharmaceuticals
₹ 1,257.30
+₹19.30 (1.56%)
1D
Last updated 03 Jul, 2026, 15:58 IST

SAI LIFE SCIENCES LIMITED Share Price Today

As of 5 Jul 2026, SAI LIFE SCIENCES LIMITED share price is ₹1,257.30. The stock opened at ₹1,241.00, compared to its previous close of ₹1,238.00. During today's trading session, SAI LIFE SCIENCES LIMITED share price moved in the range of ₹1,235.60 to ₹1,260.00, with an average price of ₹1,247.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹776.25 and a high of ₹1,260.00. On the performance front, SAI LIFE SCIENCES LIMITED share price has increased by 36.41% over the last six months and is up 59.18% on a year-on-year basis.

₹1,235.60
1.56% up today
₹1,260.00
1D LOW
1D HIGH

SAI LIFE SCIENCES LIMITED Returns Calculator

Open
₹1,241.00
High
₹1,260.00
Low
₹1,235.60
Prev. close
₹1,238.00
Circuit
L
H
₹1,005.90
₹1,508.70
52-week
L
H
₹776.25
₹1,260.00

SAI LIFE SCIENCES LIMITED Shareholder Returns

SAI LIFE SCIENCES LIMITED Share Price History

Mkt Cap Cr
26,284.20
P/E
75.31
P/B
10.58
ROE
14.05%
D/E
0.09
ROCE
18.23%
Div. Yield
0.00%
EPS(TTM)
16.27
Turnover
0.78
EV/EBITDA
39.54
Net Margin
0.00%
Op. Margin
0.00%
ROA
9.62%
Quick Ratio
0.00
Curr. Ratio
1.97
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Sai Life outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Sai Life appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Sai Life revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

SAI LIFE SCIENCES LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,694.57₹1,465.18₹1,217.14₹869.59
Other Income₹36.78₹29.09₹27.97₹28.15
Total Revenue₹1,731.35₹1,494.27₹1,245.11₹897.74
Total Expenses₹1,503.65₹1,385.04₹1,228.70₹888.05
Profit Before Tax₹227.70₹109.23₹16.41₹9.70
Tax₹57.57₹26.43₹6.42₹3.47
Profit After Tax₹170.13₹82.81₹9.99₹6.23
EPS - Basic₹8.83₹4.57₹0.55₹3.56
EPS - Diluted₹8.61₹4.53₹0.55₹3.50

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹227.70₹109.23₹16.41₹9.70
Income before WC changes₹466.77₹315.20₹188.56₹138.84
Change in Assets-₹284.74-₹11.70₹5.13-₹83.17
Change in Liabilities₹153.65-₹26.54₹29.80₹57.32
Change in WC-₹131.09-₹38.24₹34.93-₹25.85
Cash flow from Operations₹314.05₹263.09₹219.40₹104.87
Cash flow from Investing-₹536.67-₹192.38-₹101.78-₹103.71
Cash flow from Financing₹301.43-₹95.30-₹200.65₹71.92
Total Cash Flow₹78.81-₹24.59-₹83.03₹75.15
Cash (Start of the year)₹11.97₹35.53₹115.78₹40.62
Cash (End of the year)₹91.05₹11.97₹35.53₹115.77

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,655.46₹1,330.02₹1,222.70₹1,213.14
Current Assets₹1,504.51₹945.11₹963.95₹944.20
Total Assets₹3,159.98₹2,275.14₹2,186.65₹2,157.35
Current Liabilities₹732.49₹739.90₹758.85₹713.42
Net Current Asset₹772.02₹205.21₹205.10₹230.78
Non-Current Liabilities₹299.13₹560.09₹539.70₹565.36
Equity Capital₹2,128.35₹975.14₹888.09₹878.57
Total Equity & Liabilities₹3,159.98₹2,275.14₹2,186.65₹2,157.35

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,642.05₹1,418.68₹1,157.40₹841.02
Other Income₹37.34₹29.33₹27.96₹28.15
Total Revenue₹1,679.38₹1,448.01₹1,185.36₹869.17
Total Expenses₹1,447.67₹1,319.01₹1,152.68₹846.82
Profit Before Tax₹231.72₹129.01₹32.69₹22.35
Tax₹58.25₹33.77₹8.45₹6.67
Profit After Tax₹173.46₹95.23₹24.24₹15.68
EPS - Basic₹9.00₹5.26₹13.42₹8.97
EPS - Diluted₹8.78₹5.21₹13.29₹8.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹231.72₹129.01₹32.69₹22.35
Income before WC changes₹452.11₹315.04₹186.76₹132.29
Change in Assets-₹267.98-₹27.51₹18.97-₹91.48
Change in Liabilities₹167.70-₹23.39₹19.82₹55.68
Change in WC-₹100.28-₹50.90₹38.79-₹35.80
Cash flow from Operations₹330.35₹250.64₹221.47₹88.38
Cash flow from Investing-₹564.71-₹190.05-₹111.23-₹94.63
Cash flow from Financing₹314.31-₹84.63-₹190.04₹80.95
Total Cash Flow₹79.95-₹24.04-₹79.80₹74.70
Cash (Start of the year)₹5.17₹29.21₹109.01₹34.31
Cash (End of the year)₹85.12₹5.17₹29.21₹109.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹1,642.12₹1,288.75₹1,178.69₹1,162.23
Current Assets₹1,494.54₹951.17₹951.93₹943.66
Total Assets₹3,136.66₹2,239.92₹2,130.62₹2,105.89
Current Liabilities₹727.20₹723.24₹739.36₹707.57
Net Current Asset₹767.35₹227.93₹212.57₹236.09
Non-Current Liabilities₹242.00₹505.48₹478.53₹507.29
Equity Capital₹2,167.46₹1,011.20₹912.73₹891.04
Total Equity & Liabilities₹3,136.66₹2,239.92₹2,130.62₹2,105.89
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
1257.3
8
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 8
Buy orders: 0%
Sell orders: 100%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
64.58
Neutral
ATR (14)
34.39
Neutral
STOCH(9,6)
96.39
Bearish
STOCH RSI (14)
94.11
Bearish
ADX(9)
33.33
Bearish
UO(9)
57.28
Neutral
ROC(12)
4.23
Bullish
WillR(14)
-3.43
Bearish
Period
Simple value
Exponential vaue
5D
1244.26
1242.28
10D
1228.35
1231.35
20D
1215.8
1211.05
50D
1147.7
1151.56
100D
1055.94
1081.68

About SAI LIFE SCIENCES LIMITED

SAI LIFE SCIENCES LIMITED logo
ISIN
INE570L01029
Sector Market Cap
₹ 26,284.2 Cr

Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.

SAI LIFE SCIENCES LIMITED Financial Highlights

  • Revenue: SAI LIFE SCIENCES LIMITED reported revenue of ₹2,241.62 crore in FY26 vs ₹1,731.35 crore in FY25. It showed an increase of 29.47% on a yearly basis.
  • Operating Profit: SAI LIFE SCIENCES LIMITED reported an operating profit of ₹466.19 crore in FY26 vs ₹227.70 crore in FY25. It showed an increase of 104.74% on a year-on-year basis.
  • Net Profit: SAI LIFE SCIENCES LIMITED reported a net profit of ₹348.91 crore in FY26 vs ₹170.13 crore in FY25. It showed an increase of 105.08% on a yearly basis.

SAI LIFE SCIENCES LIMITED Quarterly Result Highlights

  • SAI LIFE SCIENCES LIMITED reported revenue of ₹617.66 crore in Mar 2026, compared with ₹564.84 crore in Dec 2025, representing an increase of 9.35% on a quarter-on-quarter (QoQ) basis.
  • SAI LIFE SCIENCES LIMITED reported an operating profit of ₹139.23 crore in Mar 2026, compared with ₹134.17 crore in Dec 2025, representing an increase of 3.77% on a quarter-on-quarter (QoQ) basis.
  • SAI LIFE SCIENCES LIMITED reported a profit of ₹104.24 crore in Mar 2026, compared with ₹100.38 crore in Dec 2025, reflecting an increase of 3.85% on a QoQ basis.
  • The earnings per share (EPS) of SAI LIFE SCIENCES LIMITED stood at ₹8.83 during Mar 2026.
Know more
Promoters
34.61%
FII
21.17%
Other DII
3.74%
Retail and other
12.68%
Mutual funds
27.80%
Foreign institutions - FII
Compare against other stocks
SAI LIFE SCIENCES LIMITED logo
SAI LIFE SCIENCES LIMITED
Pharmaceuticals
Add Stock
Add Another

FAQs on SAI LIFE SCIENCES LIMITED Share Price